Abstract:Many patients with severe infections receive inappropriate empirical treatment, and rapid detection of bacterial antibiotic susceptibility can improve clinical outcome and reduce mortality. To this end, we have developed a multiplex fluidic chip for rapid phenotypic antibiotic susceptibility testing of bacteria. A total of 21 clinical isolates of Escherichia coli , Klebsiella pneumoniae , and Staphylococcus aureus were acquired from the EUCAST Development Laboratory and tested against amikacin, ceftazidime, and meropenem (Gram-negative bacteria) or gentamicin, ofloxacin, and tetracycline (Gram-positive bacteria). The bacterial samples were mixed with agarose and loaded in an array of growth chambers in the chip where bacterial microcolony growth was monitored over time using automated image analysis. MIC values were automatically obtained by tracking the growth rates of individual microcolonies in different regions of antibiotic gradients. Stable MIC values were obtained within 2 to 4 h, and the results showed categorical agreement with reference MIC values as determined by broth microdilution in 86% of the cases. IMPORTANCE Prompt and effective antimicrobial therapy is crucial for the management of patients with severe bacterial infections but is becoming increasingly difficult to provide due to emerging antibiotic resistance. The traditional methods for antibiotic susceptibility testing (AST) used in most clinical laboratories are reliable but slow with turnaround times of 2 to 3 days, which necessitates the use of empirical therapy with broad-spectrum antibiotics. There is a great need for fast and reliable AST methods that enable starting targeted treatment within a few hours to improve patient outcome and reduce the overuse of broad-spectrum antibiotics. The multiplex fluidic chip for phenotypic AST described in the present study may enable data on antimicrobial resistance within 2 to 4 h, allowing for an early initiation of appropriate antibiotic therapy.

Rapid and Accurate Antimicrobial Susceptibility Testing Using Label‐Free Electrical Impedance‐Based Microfluidic Platform (Small 6/2024)

Rapid and Accurate Antimicrobial Susceptibility Testing Using Label-Free Electrical Impedance-Based Microfluidic Platform

All-electrical antibiotic susceptibility testing within 30 min using silicon nano transistors

Microfluidic Systems for Rapid Antibiotic Susceptibility Tests (asts) at the Single-Cell Level

Rapid Antibiotic Susceptibility Testing in A Microfluidic Ph Sensor

Combinatorial Screening SlipChip for Rapid Phenotypic Antimicrobial Susceptibility Testing

Integrated Microfluidic Chip for Rapid Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures

Microfluidic Technologies for Advanced Antimicrobial Susceptibility Testing

Handyfuge Microfluidic for On-Site Antibiotic Susceptibility Testing

Dual-modal Detection of Antimicrobial Susceptibility in Pathogenic Bacteria Based on the High-Throughput Microfluidic Platform

Precise Digital Bacteria Enumeration and Antibiotic Susceptibility Testing Via a Portable Vibrating Capillary-Based Droplet Platform

Phase Contrast Image-Based Rapid Antimicrobial Susceptibility Testing of Bacteria in Liquid Culture Media

A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing

Rapid phenotypic antimicrobial susceptibility testing using nanoliter arrays

Under-oil open microfluidic systems for rapid phenotypic antimicrobial susceptibility testing

A Cascaded Droplet Microfluidic Platform Enables High-throughput Single Cell Antibiotic Susceptibility Testing at Scale

Rapid antibiotic susceptibility testing and species identification for mixed infections

Controlled-diffusion centrifugal microfluidic for rapid antibiotic susceptibility testing

A capillary-based centrifugal indicator equipped with in-situ pathogenic bacteria culture for fast antimicrobial susceptibility testing

Fiber-integrated cantilever-based nanomechanical biosensors as a tool for rapid antibiotic susceptibility testing

All-electrical monitoring of bacterial antibiotic susceptibility in a microfluidic device